The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetic (PK) modeling of serum platinum to reveal extent of long-term exposure and associated comorbidities after cisplatin treatment.
 
Omar El Charif
No Relationships to Disclose
 
Zepeng Mu
No Relationships to Disclose
 
Eric R Gamazon
No Relationships to Disclose
 
Paul C Dinh
No Relationships to Disclose
 
Shirin Ardeshirrouhanifard
Employment - Lilly (I)
 
Patrick O. Monahan
No Relationships to Disclose
 
Darren R. Feldman
Research Funding - Novartis; Seagen
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen; Celgene
Consulting or Advisory Role - Celgene
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Bayer
Research Funding - Janssen
Travel, Accommodations, Expenses - Janssen
 
David J. Vaughn
Research Funding - Merck Sharp & Dohme; Roche/Genentech
 
Neil E. Martin
Consulting or Advisory Role - Via Oncology
 
Chunkit Fung
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Astellas Pharma; Exelixis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Sophie D. Fossa
Honoraria - Astellas Oncology
 
Lois B. Travis
No Relationships to Disclose
 
M. Eileen Dolan
No Relationships to Disclose